Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy

Clinical Immunology

Volumn 156, Issue 2, 2015, Pages 154-162

  Jonkman Berk, B M ^a   van den Berg, J M ^a   ten Berge, I J M ^b   Bredius, R G M ^c   Driessen, G J ^d   Dalm, V A S H ^e   van Dissel, J T ^c   van Deuren, M ^f   Ellerbroek, P M ^g   van der Flier, M ^f   van Hagen, P M ^e   van Montfrans, J M ^h   Rutgers, A ⁱ   Scholvinck E H ^j   de Vries, E ^k   van Beem, R T ^l   Kuijpers, T W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j UNIVERSITY OF GRONINGEN   (Netherlands)

^k JEROEN BOSCH HOSPITAL   (Netherlands)

^l CENTRAL LABORATORY   (Netherlands)

more..

Author keywords

Infection; Malignancy; Primary immunodeficiencies; Transplantation

Indexed keywords

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; AGE; AGED; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RISK; CHILD; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; COMPARATIVE STUDY; COMPLEMENT DEFICIENCY; CONSANGUINITY; DELAYED DIAGNOSIS; DISEASE REGISTRY; DNA STRAND BREAKAGE; ENDOCRINE TUMOR; FEMALE; GASTROINTESTINAL TUMOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOGLOBULIN DEFICIENCY; INCIDENCE; INFANT; KIDNEY TRANSPLANTATION; LEUKEMIA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEWBORN; NONHODGKIN LYMPHOMA; PATIENT RISK; PHAGOCYTE DYSFUNCTION; PREVALENCE; PRIMARY ANTIBODY DISORDER; PRIORITY JOURNAL; RISK FACTOR; SEVERE COMBINED IMMUNODEFICIENCY; SEX DIFFERENCE; SEX RATIO; SKIN CANCER; SKIN CARCINOMA; THYMOMA; AGE DISTRIBUTION; EUROPE; IMMUNOLOGIC DEFICIENCY SYNDROMES; NEOPLASMS; REGISTER; RISK; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; NEOPLASMS; NETHERLANDS; PREVALENCE; REGISTRIES; RISK; SEX DISTRIBUTION;

EID: 84921491666     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.10.003     Document Type: Article

References (37)

1. Al-Herz W., Bousfiha A., Casanova J.L., Chapel H., Conley M.E., Cunningham-Rundles C., et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front. Immunol. 2011, 2:54.
2. Parvaneh N., Casanova J.L., Notarangelo L.D., Conley M.E. Primary immunodeficiencies: a rapidly evolving story. J. Allergy Clin. Immunol. 2013, 131(2):314-323.
3. Group CTFPs The French national registry of primary immunodeficiency diseases. Clin. Immunol. 2010, 135(2):264-272.
4. Kilic S.S., Ozel M., Hafizoglu D., Karaca N.E., Aksu G., Kutukculer N. The prevalences and patient characteristics of primary immunodeficiency diseases in Turkey-two centers study. J. Clin. Immunol. 2013, 33(1):74-83.
5. Gathmann B., Goldacker S., Klima M., Belohradsky B.H., Notheis G., Ehl S., et al. The German national registry for primary immunodeficiencies (PID). Clin. Exp. Immunol. 2013, 173(2):372-380.
6. Matamoros Flori N., Mila Llambi J., Espanol Boren T., Raga Borja S., Fontan Casariego G. Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults. J. Clin. Immunol. 1997, 17(4):333-339.
7. Kirkpatrick P., Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J. Clin. Immunol. 2007, 27(5):517-524.
8. Gathmann B., Grimbacher B., Beaute J., Dudoit Y., Mahlaoui N., Fischer A., et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin. Exp. Immunol. 2009, 157(Suppl. 1):3-11.
9. Guzman D., Veit D., Knerr V., Kindle G., Gathmann B., Eades-Perner A.M., et al. The ESID Online Database network. Bioinformatics 2007, 23(5):654-655.
10. (NKR). NK. Cijfers over Kanker [cited 2013]. Available at:, (Accessed September 9, 2013). http://www.cijfersoverkanker.nl.
11. Database ESfIO [cited 2013]. Available at:, (Accessed July 30, 2013). http://www.esid.org/statistics.php.
12. Reda S.M., Afifi H.M., Amine M.M. Primary immunodeficiency diseases in Egyptian children: a single-center study. J. Clin. Immunol. 2009, 29(3):343-351.
13. Abuzakouk M., Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J. Clin. Immunol. 2005, 25(1):73-77.
14. Gathmann B., Mahlaoui N., Deredih, Gérard L., Oksenhendler E., Warnatz K., Schulze I., et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 2014, 134(1):116-126. e11.
15. Gennery A.R., Slatter M.A., Grandin L., Taupin P., Cant A.J., Veys P., et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?. J. Allergy Clin. Immunol. 2010, 126(3). 602-10 e1-11.
16. Szabolcs P., Cavazzana-Calvo M., Fischer A., Veys P. Bone marrow transplantation for primary immunodeficiency diseases. Pediatr. Clin. North Am. 2010, 57(1):207-237.
17. Griffith L.M., Cowan M.J., Kohn D.B., Notarangelo L.D., Puck J.M., Schultz K.R., et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J. Allergy Clin. Immunol. 2008, 122(6):1087-1096.
18. Antoine C., Muller S., Cant A., Cavazzana-Calvo M., Veys P., Vossen J., et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003, 361(9357):553-560.
19. Cowan M.J., Neven B., Cavazanna-Calvo M., Fischer A., Puck J. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases. Biol. Blood Marrow Transplant. 2008, 14(1 Suppl. 1):73-75.
20. Amayiri N., Al-Zaben A., Ghatasheh L., Frangoul H., Hussein A.A. Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: single center experience in Jordan. Pediatr. Transplant. 2013, 17(4):394-402.
21. Al-Ghonaium A. Stem cell transplantation for primary immunodeficiencies: King Faisal Specialist Hospital experience from 1993 to 2006. Bone Marrow Transplant. 2008, 42(Suppl. 1):S53-S56.
22. Mitchell R., Nivison-Smith I., Anazodo A., Tiedemann K., Shaw P., Teague L., et al. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Biol. Blood Marrow Transplant. 2013, 19(3):338-343.
23. Morales P., Hernandez D., Vicente R., Sole A., Moreno I., Torres J.J., et al. Lung transplantation in patients with X-linked agammaglobulinemia. Transplant. Proc. 2003, 35(5):1942-1943.
24. Liu S., Zhang Q.D., Zhang D.L., Liu W.H. An unusual cause of renomegaly and renal insufficiency: a case report of renal involvement in common variable immunodeficiency disease. Ren. Fail. 2011, 33(1):92-95.
25. Miller B.W., Brennan D.C., Korenblat P.E., Goss J.A., Flye M.W. Common variable immunodeficiency in a renal transplant patient with severe recurrent bacterial infection: a case report and review of the literature. Am. J. Kidney Dis. 1995, 25(6):947-951.
26. Hogan M.B., Wilson N.W., Muchant D.G. Renal transplantation in a patient with common variable immunodeficiency. Am. J. Kidney Dis. 1999, 33(6):e7.
27. Fakhouri F., Robino C., Lemaire M., Droz D., Noel L.H., Knebelmann B., et al. Granulomatous renal disease in a patient with common variable immunodeficiency. Am. J. Kidney Dis. 2001, 38(2):E7.
28. Mueller B.U., Pizzo P.A. Cancer in children with primary or secondary immunodeficiencies. J. Pediatr. 1995, 126(1):1-10.
29. Vajdic C.M., Mao L., van Leeuwen M.T., Kirkpatrick P., Grulich A.E., Riminton S. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?. Blood 2010, 116(8):1228-1234.
30. Mellemkjaer L., Hammarstrom L., Andersen V., Yuen J., Heilmann C., Barington T., Bjorkander J., Olsen J.H. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin. Exp. Immunol. 2002, 130(3):495-500.
31. Salavoura K., Kolialexi A., Tsangaris G., Mavrou A. Development of cancer in patients with primary immunodeficiencies. Anticancer Res. 2008, 28(2B):1263-1269.
32. Shapiro R.S. Malignancies in the setting of primary immunodeficiency: implications for hematologists/oncologists. Am. J. Hematol. 2011, 86(1):48-55.
33. Morra M., Howie D., Grande M.S., Sayos J., Wang N., Wu C., et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu. Rev. Immunol. 2001, 19:657-682.
34. Soresina A., Lougaris V., Giliani S., Cardinale F., Armenio L., Cattalini M., et al. Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency. Eur. J. Pediatr. 2002, 161(12):656-659.
35. Filipovich A.H., Zhang K., Snow A.L., Marsh R.A. X-linked lymphoproliferative syndromes: brothers or distant cousins?. Blood 2010, 116(18):3398-3408.
36. Booth C., Gilmour K.C., Veys P., Gennery A.R., Slatter M.A., Chapel H., et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 2011, 117(1):53-62.
37. Eastwood D., Gilmour K.C., Nistala K., Meaney C., Chapel H., Sherrell Z., et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin. Exp. Immunol. 2004, 137(3):584-588.